Goldenwell Biotech, Inc. (GWLL)
OTCMKTS · Delayed Price · Currency is USD
0.2000
0.00 (0.00%)
At close: May 16, 2025
Goldenwell Biotech Company Description
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States.
It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement.
The company was incorporated in 2019 and is based in Hudson, Ohio.
Goldenwell Biotech, Inc.
| Country | United States |
| Founded | 2019 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| CEO | Shuang Liu |
Contact Details
Address: 581 Boston Mills Road Hudson, Nevada 44236 United States | |
| Phone | 440 666 7999 |
Stock Details
| Ticker Symbol | GWLL |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US38138N1046 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shuang Liu | Chairman, Chief Executive Officer and President |
| Hua Xie | Secretary and Director |
| Li Yang | Treasurer and Director |